Germany Daily Briefing

BASF (BASFY) was the session's only meaningful loser, down 3.09% to stand in sharp contrast to the Industrials sector gaining 1.21% and Autos +0.77%. The divergence is not coincidental: BASF's Verbund cost structure is uniquely exposed to European energy-price normalisation stalling and to China specialty chemicals demand running below the 2025 recovery consensus. With BAYRY (Bayer) also in the gainer column at +1.42%, the market is drawing a clear distinction between pharma-chemicals and commodity-chemicals. FAZ Finanzen reported today that institutional investors are revisiting German equity allocations — but the Anthropic and AI hardware supply-chain theme, not the legacy chemicals cycle, is driving the inflows. BASF needs a China demand catalyst or an energy price tailwind to re-enter the conversation.

FAZ Finanzen reported today that Wüstenrot & Württembergische has chosen to voluntarily exit the S-DAX index — a rare structural move in German financial markets. For MDAX and S-DAX watchers, voluntary exits typically signal either a strategic pivot away from equity-market transparency obligations or a preparation for a ownership structure change. W&W runs both the building-savings (Bausparkasse) and insurance businesses — two sectors currently in structural headwind from the German property correction and from rising claims costs. The Xetra-listed share's removal from the S-DAX reduces passive index-replication buying pressure; watch for a discount to intrinsic value opening over the next 30 days as passive funds complete their exit.

FAZ Finanzen published today an extended interview with Tom Slater, the Baillie Gifford fund manager and Anthropic backer, explaining the investment thesis — a direct signal that European institutional capital is rotating toward AI infrastructure plays. For German equity investors, this matters because it frames the SAP (implied by Xetra's tech allocation) and Siemens Healthineers (SIEGY +1.44%) positioning: the market is distinguishing between companies with genuine AI workflow integration and those with superficial AI branding. Siemens Healthineers's co-marketing agreement with Mureva Phototherapy announced this week is a micro-example of the same logic. The FAZ interview makes explicit what the session's sector leadership already showed — German industrials and tech are re-rating on AI-integration conviction, not just on China recovery hopes.